MBX
MBX Biosciences, Inc.
57.72
+1.39 (+2.47%)
52w low 23.07
72.64 high
69.9% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Operating Cash Flow | -23.12M | -31.98M | -54.68M | -79.95M | |
| Depreciation & Amort | 56.00K | 157.00K | 244.00K | 248.00K | |
| Capital Expenditure | -441.00K | -129.00K | -874.00K | -1.93M | |
| Free Cash Flow | -23.56M | -32.11M | -55.55M | -81.88M | |
| Investing Cash Flow | -11.41M | -30.93M | -160.59M | -83.70M | |
| Financing Cash Flow | 46.06M | 69.22M | 234.10M | 189.59M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--